AMX0035 and Progressive Supranuclear Palsy

NCT06122662 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Supranuclear Palsy
PSP
Neurodegenerative Diseases
Atypical Parkinsonism

Interventions

DRUG: AMX0035
OTHER: Placebo

Sponsor

Amylyx Pharmaceuticals Inc.